Safety and Tolerability of AFFITOPE AD03

Summary

This is a randomized, controlled, parallel group, patient-blinded, single-center, phase I pilot study to assess tolerability and safety of repeated subcutaneous administration of a single-dose of AFFITOPE AD03 applied with or without adjuvant to patients with mild to moderate Alzheimer's disease.

Timeline

Start

2010-10

Primary completion

2011-09

Completion

2011-11

Drugs

Indications